Brief: Hamlet Pharma Gets SEK 12.95 Million Via Exercise Of Warrants
07/10/2019 07:57
Oct 7 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* GETS SEK 12.95 MILLION VIA EXERCISE OF WARRANTS
Source text for Eikon: ID:nWkr7DgbzV
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe